ALLO
Allogene Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.40
-0.07 ▼ -2.83%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$2.35
-0.05 ▼ -2.08%
| Index | RUT | P/E | - | EPS (ttm) | -0.87 | Insider Own | 33.47% | Shs Outstand | 0.23B | Perf Week | 4.35% |
| Market Cap | 0.59B | Forward P/E | - | EPS next Y | 0.45% | Insider Trans | -0.35% | Shs Float | 0.15B | Perf Month | 45.45% |
| Enterprise Value | 0.42B | PEG | - | EPS next Q | -0.19 | Inst Own | 49.74% | Short Float | 16% | Perf Quarter | 62.16% |
| Income | -0.19B | P/S | - | EPS this Y | 5.02% | Inst Trans | 2.4% | Short Ratio | 4.66 | Perf Half Y | 105.13% |
| Sales | 0.00B | P/B | 1.88 | EPS next 5Y | 4.81% | ROA | -39.58% | Short Interest | 23.93M | Perf YTD | 75.18% |
| Book/sh | 1.28 | P/C | 2.34 | EPS past 3/5Y | 28.61% 16.08% | ROE | -53.42% | 52W High | -14.29% ($2.80) | Perf Year | 26.98% |
| Cash/sh | 1.03 | P/FCF | - | Sales past 3/5Y | - | ROIC | -51.93% | 52W Low | 178.39% ($0.86) | Perf 3Y | -57.3% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.97% | Gross Margin | - | Volatility(W/M) | 9.77% 9.32% | Perf 5Y | -93.76% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.2 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.93 | EPS Q/Q | 39.67% | Profit Margin | - | RSI (14) | 54.58 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.93 | Sales Q/Q | - | SMA20 | 0.31% ($2.39) | Beta | 0.52 | Target Price | $7.36 |
| Payout | - | Debt/Eq | 0.28 | Earnings | 3000000 | SMA50 | 24.77% ($1.92) | Rel Volume | 0.98 | Prev Close | $2.47 |
| Employees | 152 | LT Debt/Eq | 0.26 | EPS/Sales Surpr. | 24.61% -100% | SMA200 | 68.36% ($1.43) | Avg Volume(3M) | 5.13M | Price | $2.4 |
| IPO | 2018/10/11 | Option/Short | Yes/Yes | Trades | 14420 | Volume | 5,032,911 | Change | -2.83% |
뉴스 로딩 중...